Kratom's Wellness Marketing Masks Deadly Synthetic Risks

2 min read
Source: The New York Times
Kratom's Wellness Marketing Masks Deadly Synthetic Risks
Photo: The New York Times
TL;DR

Kratom is increasingly marketed as a wellness product for energy and focus, but health officials warn that synthetic derivatives like 7-OH pose severe addiction and overdose risks. While some outlets highlight its use in opioid recovery, others report fatal outcomes and push for stricter federal and state regulations.

Key points

  • Kratom is promoted via gyms and influencers as a performance enhancer, despite risks of addiction and liver injury.
  • The synthetic compound 7-OH, derived from kratom, is significantly more potent than morphine and lacks FDA oversight.
  • Austin health officials report rising unknown opioid deaths linked to kratom products, even as fentanyl deaths decline.
  • New York lawmakers passed a kratom ban in June, but it awaits the governor's signature amid family advocacy campaigns.

Background

Recent archive coverage highlights a broader trend of synthetic opioids hidden in supplements, such as the death of a San Francisco scientist from an undisclosed compound in a cat's claw product. This follows earlier reports on the Stunkel family's campaign in New York for stricter kratom regulations.

How outlets are covering it

The New York Times emphasizes the disconnect between kratom's wellness marketing and its potential for addiction and fatal overdose. WKBW focuses on the personal tragedy of the Stunkel family, highlighting the lack of FDA regulation and the dangers of 7-OH sold in vape shops. FOX 7 Austin provides a public health perspective, noting that while fentanyl deaths in Travis County have dropped 35%, unknown opioid deaths linked to kratom are rising. DailyTimes.com appears to be a non-news source containing only login and registration forms, offering no substantive reporting on the story.

Why it matters

The rise of kratom as a 'wellness' product obscures the dangers of unregulated synthetic opioids, leading to preventable deaths and complicating overdose treatment. Without clear federal standards for 7-OH concentrations, consumers face significant health risks from products sold in convenience stores and online.

What to watch

Regulators are moving to limit 7-OH concentrations in kratom products, and state-level bans, such as the one in New York, are pending executive action. Health officials urge consumers to read labels carefully and avoid combining kratom with other substances.

Share this article

Want the full story? Read the original reporting

Read on The New York Times